Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness

Key facts

Sponsor

Charles Drew University of Medicine and Science

Principal Investigator

Nina T. Harawa, PhD; MPH

UCLA; Charles R. Drew University of Science

Intervention

Intervention-Passport and Peer Mentor(behavioral)

Enrollment

105 enrolled

Eligibility

18 years · MALE

Timeline

2015 – 2018

Study locations (2)

• Los Angeles Centers for Alcohol and Drug Abuse (LA CADA), Los Angeles, California, United States
• Charles Drew University of Medicine and Science, Los Angeles, California, United States

Collaborators

University of California, Los Angeles · University of Southern California · Los Angeles Centers for Alcohol and Drug Addiction (L.A. CADA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Multiple endocrine neoplasia type 1

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06430021
  Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation
  Centre Hospitalier Universitaire Dijon
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04530916
  Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women
  Colorado State University
• RECRUITINGNCT03966612
  Study and Monitoring of Multiple Endocrine Neoplasia Type 1
  Centre Hospitalier Universitaire Dijon
• RECRUITINGNCT03348501
  Study and Follow-up of Multiple Endocrine Neoplasia Type 1
  Centre Hospitalier Universitaire Dijon
• ACTIVE NOT RECRUITINGNCT03048279
  Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2
  M.D. Anderson Cancer Center

See all trials for Multiple endocrine neoplasia type 1 →